One of the objectives of the 2017 National Prevalence Survey (ENP) was to measure and describe the prevalence of patients treated with antibiotics in healthcare facilities and to compare...

Introduction - Cardiovascular diseases (CVD) and stroke are responsible for more than 200,000 deaths each year in France. Few recent studies have described the French population’s...

Introduction - Myocardial infarction (MI) is a major cause of morbidity and mortality in France. Early recognition of MI symptoms and calling the Emergency Medical Services (EMS) are...

Introduction - Cardiovascular diseases (CVD) are the second leading cause of death in France and the third leading cause of premature death. The objective of our study was to describe...

Introduction - The objective of this study was to compare the incidence and characteristics of occupational diseases among temporary workers and employees with permanent contracts in...

Chlordecone is a pesticide that was used between 1973 and 1993 in Martinique and Guadeloupe to control the banana weevil. Its use has led to persistent contamination of soil, river...

The general public is exposed to a wide variety of chemicals through the air, water, soil, food, consumer products, or during occupational activities. Human biomonitoring (BM) measures...

Biomonitoring makes it possible to characterize population exposure to multiple chemical substances and to generate data useful for assessing health risks and impacts. It is an essential...

In France, published prevalence estimates for pervasive developmental disorders (PDD) and/or autism spectrum disorders (ASD) are rare and limited to data collected by the two French...

Tuberculosis surveillance in France is based on mandatory reporting of active tuberculosis cases and treatment outcomes 12 months after treatment initiation. French Guiana is one of the...